Dynamic evaluation of the hepatic uptake and clearance of manganese- based MRI contrast agents: A 31P NMR study on the isolated and perfused rat liver

Journal of Magnetic Resonance Imaging

Volumn 8, Issue 3, 1998, Pages 663-669

  Colet, Jean Marie ^a   Elst, Luce Vander ^a   Muller, Robert N ^a  

^a UNIVERSITY OF MONS   (Belgium)

Author keywords

31P spectroscopy; Liver; MnCl2; MnDPDP; MRI contrast agent; Perfused organ

Indexed keywords

CALCIUM CHANNEL; MANGAFODIPIR; MANGANESE CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; INTERNALIZATION; LIVER DISEASE; LIVER PERFUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM CHANNELS; CHLORIDES; CONTRAST MEDIA; CULTURE TECHNIQUES; EDETIC ACID; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MANGANESE; MANGANESE COMPOUNDS; PERFUSION; PYRIDOXAL PHOSPHATE; RATS; RATS, WISTAR;

EID: 0031806894     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880080322     Document Type: Article

References (24)

1. Lauterbur PC, Mendonca Dias MH, Rudin AM. Augmentation of tissue water proton spin-lattice relaxation rates by the in vivo addition of paramagnetic ions. In: Dutton PL, Leigh JS, Scarpa S, eds. Frontiers of biological energetics. New York: Academic, 1978.
2. Utter MF. The biochemistry of manganese. Med Clin North Am 1976; 60(4):713-727.
3. Davis CD, Zech L, Greger JL. Manganese metabolism in rats: an improved methodology for assessing gut endogenous losses. Proc Soc Exp Biol Med 1993; 202:103-108.
4. Tsalev DL, Zaprianov ZK. Atomic absorption spectrometry in occupational and environmental health practice. Boca Raton: CRC Press, 1983; 65-156.
5. Wolf GL, Baum L. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. Am J Roentgenol 1983; 141:193-197.
6. Rocklage SM, Cacheris WP, Quay SC, Hahn FE, Raymond KN. Manganese (H) N,N′-dipyridoxylethylenediamine-N,N′-diacetate 5,5′ bis (phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg Chem 1989; 28(3):477-485.
7. Vogl TJ, Hamm B, Schnell B, et al. MnDPDP enhancement patterns of hepatocellular lesions on MR images. J Magn Reson Imaging 1993; 3:51-58.
8. Grant D, Zech K, Holtz E. Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest Radiol 1994; 29:5249-5250.
9. Lim KO, Stark DD, Leese PT, Pfefferbaum A, Rocklage SM, Quay SC. Hepatobiliary MR imaging: first human experience with MnDPDP. Radiology 1991; 178:79-82.
10. Gehl H-B, Vorwerk D, Klose K-C, Günther RW. Pancreatic enhancement after low-dose infusion of MnDPDP. Radiology 1991; 180:337-339.
11. Gehl H-B, Urhahn R, Bohndorf K, et al. MnDPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. Radiology 1993; 186:795-798.
12. Baba Y, Lerch MM, Tanimoto A, et al. Enhancement of pancreas and diagnosis of pancreatitis using manganese dipyridoxyl diphosphate. Invest Radiol 1994; 29:S300-S301.
13. White DL, Tongol JM, Roco CL, et al. Clearance, excretion, and organ distribution of Mn from the MRI contrast agent manganese-dipyridoxal-diphosphate (MnDPDP). In: Proceedings of the 7th annual scientific meeting of the Society of Magnetic Resonance in Medicine. San Francisco: Society of Magnetic Resonance in Medicine, 1988; 531.
14. Maton F, Van Haverbeke Y, Muller RN. A minimum protocol for characterization of paramagnetic contrast media. In: Proceedings of the 7th annual scientific meeting of the Society of Magnetic Resonance in Medicine. San Francisco: Society of Magnetic Resonance in Medicine, 1988; 30.
15. Muller RN, Maton F, Van Haverbeke Y. Characterization of MRI contrast media by nuclear magnetic relaxation spectroscopy. Diagn Imag Int 1988; 4(6):62-63.
16. Toft KG, Hustvedt SO, Martinsen I, Gordon PB. Metabolism, distribution and excretion of mangafodipir trisodium injection (MnDPDP) in healthy volunteers. MAGMA 1996; 4(2, suppl):298.
17. 31P studies. J Chem Phys 1965; 43(9):3123-3132.
18. 31P Fourier-transform nuclear magnetic resonance. Eur J Biochem 1973; 38:54-58.
19. Delmas-Beauvieux M-C, Gallis J-L, Rousse N, Clerc M, Canioni P. Phosphorus-31 nuclear magnetic resonance of isolated rat liver during hypothermic ischemia and subsequent normothermic perfusion. J Hepatol 1991; 1:1-10.
20. Kass GEN, Llopis J, Chow SC, Duddy SK, Orrenius S. Receptor-operated calcium influx in rat hepatocytes. Identification and characterization using manganese. J Biol Chem 1990; 265(29): 17486-17492.
21. Striggow F, Bohnensack R. Verapamil and diltiazem inhibit receptor-operated calcium channels and intracellular calcium oscillations in rat hepatocytes. FEBS Lett 1993; 318(3):341-344.
22. Toft KG, Hustvedt SO, Grant D, et al. Metabolism and pharmacokinetics of mangafodipir trisodium (MnDPDP) in man. Acta Radiol 1997; 38:677-689.
23. Colet J-M. Study of hepatic internalization mechanisms of molecular and nonarticular systems, contrast agents for magnetic resonance imaging. Doctoral Thesis. Belgium: University of Mons-Hainaut, 1994.
24. 2 and MnDPDP on the isolated and perfused rat heart. Invest Radiol 1997 (in press).